Topic Listing for NuVasive

Ability Ability Protect Intellectual Property Proprietary Technology Through Patents
Accounting Certain Investments Debt Equity Securities Accounting Equity Instruments Issued Other Employees Acquiring Conjunction
Accounting Impairment Disposal Long-lived Assets Accounting Income Taxes
Accounting Stock Appreciation Rights Other Variable Option Award Accounting Stock Issued Employees
Accounting Stock-based Compensation Accounting Stock-based Compensation-transition Disclosure
Accounting Treatment Accounts Payable Accrued Liabilities
Accounts Receivable Related Valuation Account Achievement Certain Milestones Related Acquisitions Required Make Payments
Acquisitions Unsuccessful Business Harmed Additional Agreements
Adjustments Changes Capitalization Merger Change Control Administration
Adverse Changes Reimbursement Procedures Payors Impact Ability Market After Relocate New Headquarters Not Able Sublease Current
Aggregated Option Exercises 2004 Year-end Values Agreed Parties After Effective Date Provided 127
Agreement Agrees Provide Nuvasive Copy Certificate Insurance Request Advanced
Alexis Lukianov Allograft Implants Technologies Become Subject Significantly Greater Regulation
Allowance Doubtful Accounts Always Incurred Losses Significant Total Operating Since Inception
Amendment Termination 2004 Plan Analyze Phase
Anti-takeover Provisions Organizational Documents Delaware Law Discourage Prevent Asset Purchase Agreement
Assignment Intellectual Property Rights Aster Echnology Ervices Greement
Authority Authorization
Automatic Annual Increase Share Reserve Background
Basis Presentation Basis Presentation Principles Consolidation
Because Allograft Implants Entail Risk Injury Human Recipients Because Significant Stock Ownership Executive Officers Directors Principal
Become Involved Securities Class Action Litigation Divert Managements Become Subject Product Liability Claims Required Pay Damages
Beneficial Ownership Reporting Compliance Binding Obligation Btc Enforceable Against Accordance Terms Except
Board Approval Board Committees
Board Directors Board Independence
Board Meetings Committees Bonus Awards
Bonus Plan Booth 203
Btc Report Writing Form Supplied Nuvasive Root Causes Btcs Confidential Information
Build Phase Business Combination
Business Combination Asset Acquisitions Business Combinations Asset Acquisitions
Buyer Buyers Conditions Closing
Cash Awards Cash Compensation
Cash Equivalents Short-term Investments Certain Relationships Related Transactions
Certification Chief Executive Officer Pursuant 302 Sarbanes-oxley Act Certification Chief Financial Officer Pursuant 302 Sarbanes-oxley Act
Certifications Certifications Chief Executive Officer Financial Pursuant Usc 1350
Changes Capitalization Charter
Chief Executive Officer Compensation Choose Acquire New Complementary Businesses Products Technologies Instead
Claims Relating Improper Handling Storage Disposal Biological Hazardous Claims Relating Making Improper Payments Physicians Consulting Services
Classic Fusion Clearance Pathway
Clinical Advisory Board Clinical Trials
Clinical Trials Current Future Product Candidates Not Produce Closing
Closing Buyer Shall Deliver Seller Each Following Closing Seller Shall Deliver Buyer Each Following
Code Ethics Commercially Successful Convince Spine Surgeons Products Attractive Alternative
Common Stock Common Stock Market Price
Common Stock Par Value 0001 Per Share Common Stock Reserved Future Issuance
Communications Directors Comparison Cumulative Total Return Among Nuvasive Inc Nasdaq
Compensation Committee Interlocks Insider Participation Compensation Committee Report Executive
Compensation Program Process Competition
Compliance Components Compensation
Composition Comprehensive Income
Comprehensive Loss Concentration Credit Risk Significant Customers
Conference Call Confidentiality Intellectual Property
Consents Consolidated Statements Operations
Continue Incur Increased Costs Result Recently Enacted Proposed Continue Introduce New Creative Products
Contractual Obligations Commitments Controls Procedures
Convertible Preferred Stock Corporate Governance
Corporate Information Cost Goods Sold
Critical Accounting Policies Current Treatments Spine Disorders
Currently Involved Patent Litigation Action Involving Medtronic Not Deductibility Executive Compensation
Deferred Stock-based Compensation Delivery Title
Demand Minimally Invasive Alternatives Departure Directors Principal Officers Election Appointment
Depend Clinical Investigators Sites Enroll Patients Trials Other Depend Limited Number Sources Human Tissue Allograft Implants
Dependent Senior Management Team Key Clinical Advisors Scientific Dependent Services Alexis Lukianov Keith Valentine Loss Either
Dependent Single Source Suppliers Manufacturers Certain Devices Components Dependent Single Source Suppliers Manufacturers Certain Products Components
Deploy Phase Description Business
Determining Executive Compensation Development Projects
Device Manufacture Device Specification Forms
Director Compensation Director Fee Option Grants
Director Nomination Director Nominations
Director Summary Compensation Table Disclosure Regarding Forward-looking Statements
Disclosures Segments Enterprise Related Information Distribution Stock Btc Shall Fifo Out Inventory Procedures
Dividend Policy Documents Incorporated Reference
Early Termination Agreement Terminated Otherwise Provided Follows Eileen
Elements Executive Compensation Program Eligibility
Employee Retirement Plan Employees
Employment Agreements Employment Agreements Potential Payments Termination Change Control
Employment Change Control Agreements Encounter Difficulties Integrating Acquired Products Technologies Businesses Adversely
Enforcement Entire Agreement Amendment
Entry Material Definitive Agreement Entry Material Definitive Agreement 201 Completion Acquisition
Equity Compensation Equity Compensation Plan Information
Estimates Exact Name Registrant Specified Charter
Except Share Per Data Excess Obsolete Inventory
Executing Lock-up Letter Agreement Execution Delivery Agreements
Executive Compensation Executive Officers
Executive Officers Significant Employees Exercise Option Form Consideration
Exercise Price Exhibits
Exhibits Each Agreement Shall Considered Part Hereof Set Expand Sales Marketing Efforts
Expect Price Common Stock Fluctuate Substantially Potentially Adversely Fail Obtain Experience Significant Delays Obtaining Fda Clearances
Fail Properly Manage Anticipated Growth Business Suffer Failure Build Effective Dedicated Distribution Network Products Significantly
Failure Continue Building Effective Exclusive Distribution Network Products Failure Efforts Successfully Generate Business Hospitals Following Surgeon
Failure Efforts Train Spine Surgeons Significantly Reduce Market Fair Value Financial Instruments
Favorable Demographics Fdas Premarket Clearance Approval Requirements
Federal Income Tax Consequences Awards Financial Statements Exhibits
Forecast Inventory Forgiveness Loans Executive Officers
Form 10-k Form 10-k 2006
Form 10-k 2007 Form 10-k 2008
Form 10-q Former Name Address Changed Since Last Report
Forward-looking Statements Prove Inaccurate Future Capital Needs Uncertain Need Raise Additional Funds
Future Sales Common Stock Depress Price Future Success Depends Ability Timely Develop Introduce New
Future Success Depends Ability Timely Introduce New Products General
General Administrative General Philosophy Objectives
General Provisions Governing Law Venue
Gratia Gross Margin
Gross Profit Guidance
Hansen Yuan Healthcare Fraud Abuse
Highlights Highly Competitive Market Segment Face Competition Large Well-established
Hospitals Unable Obtain Sufficient Reimbursement Procedures Performed Products Human Cell Tissue Cellular Based Products
Important Notice Regarding Availability Proxy Materials Stockholder Meeting In-process Research Development
Increased Implants Indemnification
Indemnification Agreements Indemnification Buyer
Indemnification Certain Directors Executive Officers Index
Index Consolidated Financial Statements Industry Background Market
Information Required Set Forth Proxy Statement Incorporated Report Initial Sale Time
Inspection Records Insurance
Insurance Notice Claims Intellectual Property
Intellectual Property Purchase Agreement Intellectual Property Purchase Agreement Addendum
Interest Other Expense Net Interest Other Income Expense Net
Interest Other Income Net International
Inventories Inventory
Issuances Options Jack Blair
James Blair Phd Labeling Ifu Specifications Sample Labels
Legal Proceedings Lesley Howe
Limited Operating History Incurred Significant Losses Since Inception Limited Sales Marketing Experience Efforts Largely Dependent Parties
Liquidity Capital Resources Loaner Equipment
Loaners Lock-up Letter Agreement
Maintain Phase Manufacturing Process Records
Manufacturing Supply Market Opportunity
Marketing Costs Mas
Mas Biologics Mas Maxcess
Mas Neurovision Mas Platform
Mas Platform Expansion Mas Revenue
Mas Specialized Implants Mas-maxcess
Mas-neurovision Mas-specialized Implants
Master Technology Services Agreement Master Technology Services Agreement Amendment
Maximizes Access Maximum Access Surgery Mas
Medical Device Industry Characterized Patent Litigation Become Subject Medidata Services
Meetings Membership
Merger Change Control Milestone Payment
Minimally Invasive Surgical Procedures Mix Compensation
Modifications Marketed Products Require New 510 Clearances Premarket Motion Preservation-total Disc Replacement Products
Net Loss Per Share New Products
Nominees Continuing Directors Non-discretionary Grants Outside Directors
Non-gaap Information Nontransferability Awards
Not Able Sublease Former Headquarters Receive Rental Income Not Able Timely Develop New Products Product Enhancements
Not Applicable Not Intend Pay Cash Dividends
Notes Payable Notice Annual Meeting Stockholders
Notices Now Therefore
Number 000-50744 Nuvasive
Nuvasive Completes Follow-on Public Offering Nuvasive Inc
Nuvasive Reconfirms 2005 Full Revenue Guidance Nuvasive Solution Maximum Access Surgery Mas
Nuvasives Confidential Information Nuvasives Representations Warranties Covenants
Operating Expenses Option Exercises
Option Exercises Stock Vested Options Granted Last
Other Agreements Other Information
Other Matters Other Responsibilities
Outstanding Securities Quorum Oversight Financial Reporting Other Disclosure
Oversight Independent Auditor Overview
Overview Compensation Philosophy Program Ownership Intellectual Property Rights
Packing Labeling Ifu Specifications Part
Part Incorporates Information Reference Definitive Proxy Statement Annual Part Other Information
Party Intellectual Property Payments Patent Costs
Patents Payments Nuvasive Shall Promptly Pay Tissues Shipped Per
Pcd 15145 Performance Graph
Perquisites Other Benefits Pervasive Continuing Fda Regulation
Peter Farrell Phd Policy Regarding Related Party Transactions
Power Attorney Premarket Approval Pathway
Press Release Price Evaluated Adjusted Necessary Each Least Before Anniversary
Pricing Pressure Competitors Sources Medical Reimbursement Impact Ability Principal Accountant Fees Services
Proceeds Processing Transfer Responsibilities Btc
Product Shipment Costs Products Development
Products Development Motion Preservation Professional Fees Purchase Orders Terms Payment
Properties Property Equipment
Property Plant Equipment Proposal Election Directors
Proposal Ratification Independent Registered Public Accounting Firm Provide Assurance Regarding Independent Registered Public Accounting Firms
Provide Tailored Solutions Response Surgeon Needs Provides Benefits Mas Broad Application
Proxy Voting Purchase Sale Intellectual Property Rights
Purpose Purpose Powers
Pursuant Underwriting Agreement Quantitative Qualitative Disclosures Market Risk
Quarterly Financial Results Likely Fluctuate Significantly Because Sales Quarterly Royalty Payments
Reasons Rsb Acquisition Recent Accounting Pronouncements
Recent Changes Required Accounting Treatment Stock Options Had Recent Changes Required Accounting Treatment Stock Options Material
Recent Financial Crisis General Slowdown Economy Adversely Affect Recent Product Introductions
Recent Sales Unregistered Securities Recitals
Reclassifications Reduced Hospital Stays
Reduced Surgery Times Related Party Transactions
Relationship William Blair Llc Reliance Single Source Suppliers Limit Ability Meet Demand
Report Audit Committee Report Compensation Committee
Report Independent Registered Public Accounting Firm Report Independent Registered Public Accounting Firm Internal Control
Reporting Comprehensive Income Reports
Representations Representations Warranties Buyer
Representations Warranties Covenants Seller Required Vote
Research Development Responsibilities
Results Operations Results Operations Financial Condition
Revenue Revenue Recognition
Revenues Revocation Proxy
Risk Factors Risks Related Financial Results Need Financing
Risks Related Intellectual Property Potential Litigation Risks Related Securities Markets Ownership Common Stock
Robert Hunt Safety Products Not Yet Supported Long-term Clinical Data
Sales Marketing Sales Marketing Administrative
Sales Marketing Commercial Compliance San Diego
San Diego 2005 Sarbanes-oxley Act 2002
Schedule Schedule 14a
Schedule Flow-through Terms Schedule Free Writing Prospectuses Included Disclosure Package
Schedule Hosting Services Schedule Medidata Applications
Schedule Statement Work Schedule Valuation Accounts
Secondary Offering See
Selectively License Acquire Complementary Spine Products Technologies Seller
Sellers Investor Representations Severability
Severance Benefits Severance Change Control Benefits
Share Based Payments Share Reserve
Shareowners Employees Short-term Investments
Signature Page Exclusive Manufacturing Agreement Signatures
Sizes Augmentation Device Solicitation Costs
Spine Anatomy Disorders Spine Journal
Spine Surgeons Unable Obtain Sufficient Reimbursement Procedures Performed Stablish Integrated Surgical Systems Standard Care
Sterilization Specifications Stock Appreciation Rights
Stock Awards Stock Based Compensation
Stock Options Stock-based Compensation
Stockholder Proposals Annual Meeting Held 2007 Stockholder Proposals Annual Meeting Held 2008
Stockholders Sharing Same Address Strategy
Study Protocol Phase Pivotal Cerpass Subject Damages Resulting Claims Employees Wrongfully Used Disclosed
Subject Damages Resulting Claims Officers Employees Wrongfully Used Subject Litigation Regarding Cadavers Purchased Originated University California
Subsequent Events Successors Assigns
Summary Compensation Table Summary Proposal
Supplemental Information Suppliers Fail Comply Fdas Quality System Regulations Manufacture
Suppliers Subject Claims Non-compliance Fda Regulations Connection Processing Supply Agreement
Surgeon Training Education Table Contents
Tax Accounting Considerations Taxing Authority Connection Judicial Administrative Proceedings Relating Liability
Technology Term Option
Term Termination Termination Awards
Test Phase Third-party Reimbursement
Titanium Surgical Mesh System Total Revenues
Trademarks Triad Cervical Allograft System
Triad Lumbar Allograft Systems Ucla Litigation
Uses Conventional Instruments Vote Important
Warrants Whereas
Witnesseth 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki